[go: up one dir, main page]

EE200200599A - Tsüklipostiiniühend kasutamiseks diabeedivastase ravimina, seda sisaldav farmatseutiline preparaat,ühendi ja preparaadi valmistamine ning selleks vajalik mikroorganism - Google Patents

Tsüklipostiiniühend kasutamiseks diabeedivastase ravimina, seda sisaldav farmatseutiline preparaat,ühendi ja preparaadi valmistamine ning selleks vajalik mikroorganism

Info

Publication number
EE200200599A
EE200200599A EEP200200599A EEP200200599A EE200200599A EE 200200599 A EE200200599 A EE 200200599A EE P200200599 A EEP200200599 A EE P200200599A EE P200200599 A EEP200200599 A EE P200200599A EE 200200599 A EE200200599 A EE 200200599A
Authority
EE
Estonia
Prior art keywords
preparation
compound
cyclostostin
antidiabetic drug
physiologically compatible
Prior art date
Application number
EEP200200599A
Other languages
English (en)
Inventor
Vertesy Laszlo
Ehrlich Klaus
Kurz Michael
Wink Joachim
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200200599A publication Critical patent/EE200200599A/et
Publication of EE05090B1 publication Critical patent/EE05090B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • General Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EEP200200599A 2000-05-04 2001-04-25 Tsklipostiinihend kasutamiseks diabeedivastase ravimina, seda sisaldav farmatseutiline preparaat,hendi ja preparaadi valmistamine ning selleks vajalik mikroorganism EE05090B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10021731A DE10021731B4 (de) 2000-05-04 2000-05-04 Cyclipostine, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung derselben
PCT/EP2001/004652 WO2001083497A1 (de) 2000-05-04 2001-04-25 Cyclipostine, verfahren zu ihrer herstellung und verwendung derselben

Publications (2)

Publication Number Publication Date
EE200200599A true EE200200599A (et) 2004-04-15
EE05090B1 EE05090B1 (et) 2008-10-15

Family

ID=7640768

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200599A EE05090B1 (et) 2000-05-04 2001-04-25 Tsklipostiinihend kasutamiseks diabeedivastase ravimina, seda sisaldav farmatseutiline preparaat,hendi ja preparaadi valmistamine ning selleks vajalik mikroorganism

Country Status (27)

Country Link
EP (1) EP1280812B1 (et)
JP (1) JP5038572B2 (et)
KR (1) KR100779867B1 (et)
CN (1) CN1216890C (et)
AR (1) AR028398A1 (et)
AT (1) ATE288442T1 (et)
AU (2) AU6222901A (et)
BR (1) BR0110459A (et)
CA (1) CA2407808C (et)
CZ (1) CZ20023547A3 (et)
DE (2) DE10021731B4 (et)
DK (1) DK1280812T3 (et)
EE (1) EE05090B1 (et)
ES (1) ES2236234T3 (et)
HR (1) HRP20020864A2 (et)
HU (1) HUP0300306A3 (et)
IL (2) IL152612A0 (et)
MX (1) MXPA02010297A (et)
NO (1) NO330438B1 (et)
NZ (1) NZ522352A (et)
PL (1) PL358328A1 (et)
PT (1) PT1280812E (et)
RU (1) RU2266911C2 (et)
SK (1) SK15602002A3 (et)
WO (1) WO2001083497A1 (et)
YU (1) YU81502A (et)
ZA (1) ZA200208928B (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8110665B2 (en) 2003-11-13 2012-02-07 Hanmi Holdings Co., Ltd. Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
MXPA05007210A (es) 2003-11-13 2006-02-10 Hanmi Pharm Ind Co Ltd Complejo de proteina que usa un fragmento de inmunoglobulina y metodo para la preparacion del mismo.
KR100754667B1 (ko) 2005-04-08 2007-09-03 한미약품 주식회사 비펩타이드성 중합체로 개질된 면역글로불린 Ｆｃ 단편 및이를 포함하는 약제학적 조성물
EP1894601A1 (en) 2006-08-29 2008-03-05 sanofi-aventis Treating mycobacterial infections with cyclipostins
KR200453850Y1 (ko) * 2008-04-23 2011-05-30 주식회사 에이티티알앤디 수질 관리 센서 내장형 수도미터기
KR102073748B1 (ko) 2013-01-31 2020-02-05 한미약품 주식회사 재조합 효모 형질전환체 및 이를 이용하여 면역글로불린 단편을 생산하는 방법
AR096891A1 (es) 2013-07-12 2016-02-03 Hanmi Pharm Ind Co Ltd Conjugado de monómero polipéptido biológicamente activo y conjugado de fragmento fc de inmunoglobulina, que muestra aclaramiento mediado por receptor reducido, y el método para la preparación del mismo

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04145089A (ja) * 1990-10-05 1992-05-19 Nippon Kayaku Co Ltd 抗生物質ｎｋ９０１０９３、その製造法及びそれを有効成分として含有する殺虫・殺ダニ剤
AU649116B2 (en) * 1991-03-27 1994-05-12 Sankyo Company Limited New compounds, named the "Leustroducins", their preparation and their therapeutic uses
JPH0656859A (ja) * 1991-07-25 1994-03-01 Nippon Kayaku Co Ltd 抗生物質ｎｋ９０１０９３ａ、その製造法及びそれを有効成分として含有する殺虫・殺ダニ剤
RU2077204C1 (ru) * 1995-05-12 1997-04-20 Третьяков Анатолий Петрович Способ производства микробиологических препаратов

Also Published As

Publication number Publication date
CA2407808A1 (en) 2002-10-30
AU6222901A (en) 2001-11-12
ES2236234T3 (es) 2005-07-16
EP1280812A1 (de) 2003-02-05
IL152612A (en) 2009-11-18
DK1280812T3 (da) 2005-05-30
HUP0300306A3 (en) 2004-10-28
NZ522352A (en) 2004-06-25
PT1280812E (pt) 2005-05-31
DE10021731A1 (de) 2001-11-15
EE05090B1 (et) 2008-10-15
ZA200208928B (en) 2003-10-07
SK15602002A3 (sk) 2003-04-01
NO20025209D0 (no) 2002-10-30
AU2001262229B2 (en) 2007-01-25
KR100779867B1 (ko) 2007-11-27
CZ20023547A3 (cs) 2003-02-12
DE10021731B4 (de) 2005-12-08
CA2407808C (en) 2013-06-25
PL358328A1 (en) 2004-08-09
RU2266911C2 (ru) 2005-12-27
IL152612A0 (en) 2003-06-24
YU81502A (sh) 2006-05-25
JP2003531914A (ja) 2003-10-28
ATE288442T1 (de) 2005-02-15
KR20030009464A (ko) 2003-01-29
DE50105249D1 (de) 2005-03-10
AR028398A1 (es) 2003-05-07
JP5038572B2 (ja) 2012-10-03
WO2001083497A1 (de) 2001-11-08
NO330438B1 (no) 2011-04-11
NO20025209L (no) 2002-10-30
HUP0300306A2 (hu) 2003-06-28
EP1280812B1 (de) 2005-02-02
MXPA02010297A (es) 2003-04-25
BR0110459A (pt) 2003-03-11
CN1427845A (zh) 2003-07-02
CN1216890C (zh) 2005-08-31
HK1055745A1 (en) 2004-01-21
HRP20020864A2 (en) 2004-12-31

Similar Documents

Publication Publication Date Title
ATE316083T1 (de) Adamantanderivate
SE0103836D0 (sv) Novel compounds
BR0213242A (pt) Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto
NO20024772D0 (no) Percyquinnin, fremgangsmåte for dets fremstilling og dets anvendelse som et legemiddel
EA200400432A1 (ru) Производные мочевины
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
CY1112960T1 (el) Παραγωγα ουριας, μεθοδοι για την παρασκευη τους και χρησεις αυτων
HUT77627A (hu) 2,2-Diklór-alkánkarbonsavak, eljárás előállításukra és ezeket tartalmazó, inzulinrezisztencia kezelésére alkalmazható gyógyszerkészítmények
EE200000472A (et) Kasvajavastased toimeained
SE9804212D0 (sv) Compounds
MXPA02012889A (es) Esteres de acidos 4-alcoxi-ciclohexano-1-amino-carboxilicos y procedimiento para su obtencion.
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
EE200200599A (et) Tsüklipostiiniühend kasutamiseks diabeedivastase ravimina, seda sisaldav farmatseutiline preparaat,ühendi ja preparaadi valmistamine ning selleks vajalik mikroorganism
MXPA04005484A (es) Procedimiento de preparacion de derivados de equinocandina.
WO2002100327A3 (en) Substituted 1-benzazepines and derivatives thereof
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
DK1696954T3 (da) Vaccinesammensætning blandet med en alkylphosphatidylcholin
AU2002248531A1 (en) Pyrazolopyriadine derivatives
SE0202693D0 (sv) Compounds
SE0102057D0 (sv) New Salts I
SE0202692D0 (sv) Compounds
DE69917668D1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
EA200400409A1 (ru) Новые соединения изохинолина, способ их получения и фармацевтические композиции, содержащие их
AU2001244999A1 (en) Naphthamide neurokinin antagonists for use as medicaments
GEP20032928B (en) Halo Derivatives of 9-Deoxo-9a-Aza-9a-Homerythromycin A, Method for its Production, Pharmaceutical Compositions Containing the Same and Their Use for Treatment or Prevention of Bacterial Infections

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20090425